• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

评估林奇综合征患者结肠和妇科降低风险手术的有效性。

Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

作者信息

Dueñas Nuria, Navarro Matilde, Teulé Àlex, Solanes Ares, Salinas Mònica, Iglesias Sílvia, Munté Elisabet, Ponce Jordi, Guardiola Jordi, Kreisler Esther, Carballas Elvira, Cuadrado Marta, Matias-Guiu Xavier, de la Ossa Napoleón, Lop Joan, Lázaro Conxi, Capellá Gabriel, Pineda Marta, Brunet Joan

机构信息

Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.

出版信息

Cancers (Basel). 2020 Nov 18;12(11):3419. doi: 10.3390/cancers12113419.

DOI:10.3390/cancers12113419
PMID:33218006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7698735/
Abstract

BACKGROUND

Colorectal (CRC) and endometrial cancer (EC) are the most common types of cancer in Lynch syndrome (LS). Risk reducing surgeries (RRS) might impact cancer incidence and mortality. Our objectives were to evaluate cumulative incidences of CRC, gynecological cancer and all-cause mortality after RRS in LS individuals.

METHODS

Retrospective analysis of 976 LS carriers from a single-institution registry. Primary endpoints were cumulative incidence at 75 years of cancer (metachronous CRC in 425 individuals; EC and ovarian cancer (OC) in 531 individuals) and all-cause mortality cumulative incidence, comparing extended (ES) vs. segmental surgery (SS) in the CRC cohort and risk reducing gynecological surgery (RRGS) vs. surveillance in the gynecological cohort.

RESULTS

Cumulative incidence at 75 years of metachronous CRC was 12.5% vs. 44.7% ( = 0.04) and all-cause mortality cumulative incidence was 38.6% vs. 55.3% ( = 0.31), for ES and SS, respectively. Cumulative, incidence at 75 years was 11.2% vs. 46.3% for EC ( = 0.001) and 0% vs. 12.7% for OC ( N/A) and all-cause mortality cumulative incidence was 0% vs. 52.7% ( N/A), for RRGS vs. surveillance, respectively.

CONCLUSIONS

RRS in LS reduces the incidence of metachronous CRC and gynecological neoplasms, also indicating a reduction in all-cause mortality cumulative incidence in females undergoing RRGS.

摘要

背景

结直肠癌（CRC）和子宫内膜癌（EC）是林奇综合征（LS）中最常见的癌症类型。降低风险手术（RRS）可能会影响癌症发病率和死亡率。我们的目标是评估LS患者接受RRS后结直肠癌、妇科癌症的累积发病率以及全因死亡率。

方法

对来自单一机构登记处的976名LS携带者进行回顾性分析。主要终点是75岁时癌症的累积发病率（425例患者发生异时性结直肠癌；531例患者发生子宫内膜癌和卵巢癌（OC））以及全因死亡率累积发病率，比较结直肠癌队列中的扩大手术（ES）与节段性手术（SS），以及妇科队列中的降低风险妇科手术（RRGS）与监测。

结果

对于ES和SS，75岁时异时性结直肠癌的累积发病率分别为12.5%和44.7%（P = 0.04），全因死亡率累积发病率分别为38.6%和55.3%（P = 0.31）。对于RRGS与监测，75岁时子宫内膜癌的累积发病率分别为11.2%和46.3%（P = 0.001），卵巢癌为0%和12.7%（无可用数据），全因死亡率累积发病率分别为0%和52.7%（无可用数据）。

结论

LS患者接受RRS可降低异时性结直肠癌和妇科肿瘤的发病率，也表明接受RRGS的女性全因死亡率累积发病率降低。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/27f697c3f654/cancers-12-03419-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/2648d52d2260/cancers-12-03419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/9c6c237d628b/cancers-12-03419-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/27f697c3f654/cancers-12-03419-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/2648d52d2260/cancers-12-03419-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/9c6c237d628b/cancers-12-03419-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cac1/7698735/27f697c3f654/cancers-12-03419-g003.jpg

相似文献

1
Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.评估林奇综合征患者结肠和妇科降低风险手术的有效性。
Cancers (Basel). 2020 Nov 18;12(11):3419. doi: 10.3390/cancers12113419.
2
The gynecological surveillance of women with Lynch syndrome in Sweden.瑞典林奇综合征女性的妇科监测
Gynecol Oncol. 2015 Sep;138(3):717-22. doi: 10.1016/j.ygyno.2015.07.016. Epub 2015 Jul 12.
3
Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.林奇综合征患者行节段性结肠切除术的异时性结直肠肿瘤风险：基于错配修复基因状态。
J Am Coll Surg. 2020 Apr;230(4):669-675. doi: 10.1016/j.jamcollsurg.2020.01.005. Epub 2020 Jan 30.
4
Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.林奇综合征患者术后的生存结果及异时性结直肠癌风险
Ann Surg Oncol. 2017 Apr;24(4):1085-1092. doi: 10.1245/s10434-016-5633-1. Epub 2016 Oct 20.
5
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.错配修复基因突变携带者的结直肠重复癌风险：更广泛结肠手术的优势。
Gut. 2011 Jul;60(7):950-7. doi: 10.1136/gut.2010.228056. Epub 2010 Dec 30.
6
Gynecological Surveillance and Surgery Outcomes in Dutch Lynch Syndrome Carriers.荷兰林奇综合征携带者的妇科监测与手术结果
Cancers (Basel). 2021 Jan 26;13(3):459. doi: 10.3390/cancers13030459.
7
Risk of metachronous colorectal cancer after surgical resection of index rectal cancer in Lynch syndrome: a multicenter retrospective study in Japan.林奇综合征患者经直肠原发肿瘤切除术治疗后发生异时性结直肠癌的风险：日本多中心回顾性研究。
Surg Today. 2024 Sep;54(9):1075-1083. doi: 10.1007/s00595-024-02815-z. Epub 2024 Mar 19.
8
Incidence and prevalence of advanced colorectal neoplasia in Lynch syndrome.林奇综合征中晚期结直肠肿瘤的发生率和流行率。
Gastrointest Endosc. 2023 Sep;98(3):412-419.e8. doi: 10.1016/j.gie.2023.04.001. Epub 2023 Apr 7.
9
Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.遗传性非息肉病性结直肠癌（HNPCC）携带者家族中女性卵巢癌和子宫内膜癌的管理：文献综述及波兰HNPCC家族癌症风险评估结果
Hered Cancer Clin Pract. 2015 Jan 16;13(1):3. doi: 10.1186/s13053-015-0025-2. eCollection 2015.
10
Information needs of Lynch syndrome and BRCA 1/2 mutation carriers considering risk-reducing gynecological surgery: a qualitative study of the decision-making process.林奇综合征和BRCA 1/2突变携带者在考虑降低风险的妇科手术时的信息需求：对决策过程的定性研究
Hered Cancer Clin Pract. 2024 May 2;22(1):5. doi: 10.1186/s13053-024-00278-4.

引用本文的文献

1
Gynaecological cancer surveillance for women with Lynch syndrome: systematic review and cost-effectiveness evaluation.林奇综合征女性的妇科癌症监测：系统评价和成本效益评估。
Health Technol Assess. 2024 Aug;28(41):1-228. doi: 10.3310/VBXX6307.
2
Real-World Data on Institutional Implementation of Screening for Mismatch Repair Deficiency and Lynch Syndrome in Endometrial Cancer Patients.子宫内膜癌患者错配修复缺陷和林奇综合征筛查机构实施的真实世界数据。
Cancers (Basel). 2024 Feb 4;16(3):671. doi: 10.3390/cancers16030671.
3
Hereditary Women's Cancer: Management and Risk-Reducing Surgery.

本文引用的文献

1
European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.欧洲 EHTG 和 ESCP 关于林奇综合征的指南：基于基因和性别对马略卡指南的第三版更新。
Br J Surg. 2021 May 27;108(5):484-498. doi: 10.1002/bjs.11902.
2
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome Database.林奇综合征的降低风险妇科手术：来自前瞻性林奇综合征数据库的国际调查结果
J Clin Med. 2020 Jul 18;9(7):2290. doi: 10.3390/jcm9072290.
3
Analysis of morbidity and mortality, quality of life and bowel function after total colectomy with ileorectal anastomosis versus right and left hemicolectomy: A study to optimise the treatment of lynch syndrome and attenuated polyposis coli.
遗传性女性癌症：管理与降低风险手术。
Medicina (Kaunas). 2023 Feb 6;59(2):300. doi: 10.3390/medicina59020300.
4
Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.林奇综合征中子宫内膜癌或卵巢癌的筛查和降低风险手术：系统评价。
Int J Gynecol Cancer. 2022 May 3;32(5):646-655. doi: 10.1136/ijgc-2021-003132.
5
Hereditary Gynecologic Cancer Syndromes - A Narrative Review.遗传性妇科癌症综合征——一篇综述
Onco Targets Ther. 2022 Apr 8;15:381-405. doi: 10.2147/OTT.S353054. eCollection 2022.
6
Correction: Dueñas et al. Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals. 2020, , 3419.更正：杜埃尼亚斯等人。评估林奇综合征患者结肠和妇科降低风险手术的有效性。2020年，，3419。 （注：原文中两个逗号位置有些奇怪，可能存在信息不完整情况，但按要求准确翻译如上）
Cancers (Basel). 2021 Jun 22;13(13):3104. doi: 10.3390/cancers13133104.
7
How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies.我们应如何检测林奇综合征？当前指南与未来策略综述。
Cancers (Basel). 2021 Jan 22;13(3):406. doi: 10.3390/cancers13030406.
全结肠切除回肠直肠吻合术与右半结肠和左半结肠切除术治疗林奇综合征和结肠息肉病低危型的术后发病率、死亡率、生活质量和肠功能比较：优化治疗方案的研究
Eur J Surg Oncol. 2020 Sep;46(9):1613-1619. doi: 10.1016/j.ejso.2020.05.020. Epub 2020 Jun 9.
4
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.阿司匹林用于遗传性结直肠癌（林奇综合征）的癌症预防：CAPP2 研究的 10 年随访和基于登记的 20 年数据：一项双盲、随机、安慰剂对照试验。
Lancet. 2020 Jun 13;395(10240):1855-1863. doi: 10.1016/S0140-6736(20)30366-4.
5
Analysis of metachronous colorectal neoplasms and survival following segmental or extended resection in patients with hereditary non-polyposis colorectal cancer.遗传性非息肉病性结直肠癌患者行节段或扩大切除术治疗后异时性结直肠肿瘤的分析及生存情况。
Int J Colorectal Dis. 2020 Jul;35(7):1273-1282. doi: 10.1007/s00384-020-03583-1. Epub 2020 Apr 21.
6
Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.MLH1、MSH2 和 MSH6 中的致病性变异与林奇综合征患者结直肠腺瘤和肿瘤的风险及体细胞突变的相关性。
Gastroenterology. 2020 Apr;158(5):1326-1333. doi: 10.1053/j.gastro.2019.12.032. Epub 2020 Jan 8.
7
Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom Cancer Genetics Group (UKCGG).英国胃肠病学会（BSG）/英国结直肠外科学会（ACPGBI）/英国癌症遗传学组（UKCGG）遗传性结直肠癌管理指南。
Gut. 2020 Mar;69(3):411-444. doi: 10.1136/gutjnl-2019-319915. Epub 2019 Nov 28.
8
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report.林奇综合征中结肠癌分期与筛查间隔的生存率：一项林奇综合征前瞻性数据库报告
Hered Cancer Clin Pract. 2019 Oct 14;17:28. doi: 10.1186/s13053-019-0127-3. eCollection 2019.
9
Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.遗传性胃肠道癌症：ESMO诊断、治疗及随访临床实践指南†
Ann Oncol. 2019 Oct 1;30(10):1558-1571. doi: 10.1093/annonc/mdz233.
10
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.6350 名致病性错配修复变异携带者的基因、年龄和性别与癌症风险：来自前瞻性 Lynch 综合征数据库的研究结果。
Genet Med. 2020 Jan;22(1):15-25. doi: 10.1038/s41436-019-0596-9. Epub 2019 Jul 24.